Duo Yanbei, Song Shuoning, Qiao Xiaolin, Zhang Yuemei, Xu Jiyu, Zhang Jing, Peng Zhenyao, Chen Yan, Nie Xiaorui, Sun Qiujin, Yang Xianchun, Wang Ailing, Sun Wei, Fu Yong, Dong Yingyue, Lu Zechun, Yuan Tao, Zhao Weigang
Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People's Republic of China.
Department of Obstetrics, Beijing Chaoyang District Maternal and Child Health Care Hospital, Beijing, People's Republic of China.
Diabetes Ther. 2023 Dec;14(12):2143-2157. doi: 10.1007/s13300-023-01480-8. Epub 2023 Oct 16.
This study aimed to develop a simplified screening model to identify pregnant Chinese women at risk of gestational diabetes mellitus (GDM) in the first trimester.
This prospective study included 1289 pregnant women in their first trimester (6-12 weeks of gestation) with clinical parameters and laboratory data. Logistic regression was performed to extract coefficients and select predictors. The performance of the prediction model was assessed in terms of discrimination and calibration. Internal validation was performed through bootstrapping (1000 random samples).
The prevalence of GDM in our study cohort was 21.1%. Maternal age, prepregnancy body mass index (BMI), a family history of diabetes, fasting blood glucose levels, the alanine transaminase to aspartate aminotransferase ratio (ALT/AST), and the triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C) were selected for inclusion in the prediction model. The Hosmer-Lemeshow goodness-of-fit test showed good consistency between prediction and actual observation, and bootstrapping indicated good internal performance. The area under the receiver operating characteristic curve (ROC-AUC) of the multivariate logistic regression model and the simplified clinical screening model was 0.825 (95% confidence interval [CI] 0.797-0.853, P < 0.001) and 0.784 (95% CI 0.750-0.818, P < 0.001), respectively. The performance of our prediction model was superior to that of three other published models.
We developed a simplified clinical screening model for predicting the risk of GDM in pregnant Chinese women. The model provides a feasible and convenient protocol to identify women at high risk of GDM in early pregnancy. Further validations are needed to evaluate the performance of the model in other populations.
ClinicalTrials.gov identifier: NCT03246295.
本研究旨在开发一种简化的筛查模型,以识别孕早期有妊娠期糖尿病(GDM)风险的中国孕妇。
这项前瞻性研究纳入了1289例孕早期(妊娠6 - 12周)的孕妇,收集了她们的临床参数和实验室数据。进行逻辑回归以提取系数并选择预测指标。通过区分度和校准来评估预测模型的性能。通过自抽样法(1000个随机样本)进行内部验证。
我们研究队列中GDM的患病率为21.1%。预测模型纳入了产妇年龄、孕前体重指数(BMI)、糖尿病家族史、空腹血糖水平、丙氨酸转氨酶与天冬氨酸转氨酶比值(ALT/AST)以及甘油三酯与高密度脂蛋白胆固醇比值(TG/HDL - C)。Hosmer - Lemeshow拟合优度检验显示预测与实际观察之间具有良好的一致性,自抽样法表明内部性能良好。多变量逻辑回归模型和简化临床筛查模型的受试者工作特征曲线下面积(ROC - AUC)分别为0.825(95%置信区间[CI] 0.797 - 0.853,P < 0.001)和0.784(95% CI 0.750 - 0.818,P < 0.001)。我们的预测模型的性能优于其他三个已发表的模型。
我们开发了一种用于预测中国孕妇GDM风险的简化临床筛查模型。该模型为识别孕早期GDM高危女性提供了一种可行且便捷的方案。需要进一步验证以评估该模型在其他人群中的性能。
ClinicalTrials.gov标识符:NCT03246295。